Visiongain Publishes Dermatology CROs Market Report 2022-2032
The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.
Visiongain Publishes Industrial Packaging Market Report 2023-2033
The Industrial Packaging market was valued at US$8,087 million in 2022 and is projected to grow at a CAGR of 9.0% during the forecast period 2023-2033.
Visiongain Publishes Direct-to-Patient Market Report 2022-2032
The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.
Visiongain Publishes Unmanned Traffic Management (UTM) Market Report 2023-2033
The global unmanned traffic management (UTM) market was valued at US$987 million in 2022 and is projected to grow at a CAGR of 18.% during the forecast period 2023-2033.
Visiongain Publishes Dermatological Drugs Market Report 2022-2032
The Dermatology Drugs market was valued at US$24.7 billion in 2021 and is projected to grow at a CAGR of 6.2% during the forecast period 2022-2032.
Visiongain Publishes Chemical Enhanced Oil Recovery (EOR) Market Report 2022-2032
The Chemical Enhanced Oil Recovery (EOR) market was valued at more than US$4.00 billion in 2022 and is projected to grow at a CAGR of 7.8% during the forecast period 2022-2032.
Visiongain Publishes Cosmetic Surgery Market Report 2022-2032
The cosmetic surgery market was valued at US$44.31 billion in 2021 and is projected to grow at a CAGR of 9.44% during the forecast period 2022-2032.
Visiongain Publishes Antiviral Drugs Market Report 2022-2032
The antiviral drugs market was valued at US$38.96 billion in 2021 and is projected to grow at a CAGR of 3.49% during the forecast period 2022-2032.
Visiongain Publishes Lyophilisation in Pharmaceutical Market Report 2023-2033
The lyophilization in pharmaceuticals market is valued at US$252.8 billion in 2022 and is projected to grow at a CAGR of 13.0% during the forecast period 2023-2033.
Visiongain Publishes Border Security Market Report 2023-2033
The global border security market was valued at US$33,810 million in 2022 and is projected to grow at a CAGR of 7.0% during the forecast period 2023-2033.
Visiongain Publishes Critical Infrastructure Protection (CIP) Market Report 2023-2033
The global critical infrastructure protection market was valued at more than US$145 billion in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.
Visiongain Publishes HIV and HBV Therapies Market Report 2022-2032
The global HIV and HBV Therapies market is estimated to be valued at US$36.2 billion in 2022 and is projected to grow at a CAGR of 6.5% during the forecast period 2022-2032.
Visiongain Publishes Vehicle to Grid (V2G) Market Report 2023-2033
The global vehicle to grid (V2G) market was valued at US$1,014 million in 2022 and is projected to grow at a CAGR of 21.5% during the forecast period 2023-2033.
Visiongain Publishes Edge Computing Market Report 2023-2033
The global edge computing market was valued at US$39,887 million in 2022 and is projected to grow at a CAGR of 17.8% during the forecast period 2023-2033.
Visiongain Publishes Post-Consumer Recycled Plastic Market Report 2023-2033
The global post-consumer recycled plastic market was valued at US$16,239 million in 2022 and is projected to grow at a CAGR of 9.4% during the forecast period 2023-2033.
Visiongain Publishes CAR-T Therapy Market Report 2022-2032
The CAR-T Therapy market was valued at US$1.9 billion in 2021 and is projected to grow at a CAGR of 42.95% during the forecast period 2022-2032.
Visiongain Publishes Pharma Contract Sales Market Report 2022-2032
The global pharma contract sales market was valued at US$5,303.0 million in 2021 and is projected to grow at a CAGR of 5.8% during the forecast period 2022-2032.
Visiongain Publishes RNA Based Therapeutics and Vaccines Market Report 2022-2032
The RNA therapeutics market was valued at US$5,876.7 million in 2021 and is projected to grow at a CAGR of 18.68% during the forecast period 2022-2032.
Visiongain Publishes Antisense Oligonucleotide (ASO) Therapeutics Market Report 2022-2032
The antisense oligonucleotide therapeutics market was valued at US$17.46 billion in 2021 and is projected to grow at a CAGR of 13.71% during the forecast period 2022-2032.
Visiongain Publishes Viral Vectors & Plasmid DNA Manufacturing Market Report 2022-2032
The viral vectors and plasmid DNA manufacturing market was valued at US$482.3 million in 2021 and is projected to grow at a CAGR of 18.09% during the forecast period 2022-2032.
